Intravitreal aflibercept in neovascular age-related macular degeneration previously treated with ranibizumab.

2.50
Hdl Handle:
http://hdl.handle.net/11287/620341
Title:
Intravitreal aflibercept in neovascular age-related macular degeneration previously treated with ranibizumab.
Authors:
Lim, Rachel Hui Fen; Gupta, Bhaskar; Simcock, Peter
Abstract:
To report the change in visual acuity and central macular thickness (CMT) following treatment with intravitreal aflibercept injections in patients with neovascular age-related macular degeneration (nAMD) with suboptimum response to ranibizumab.
Citation:
Intravitreal aflibercept in neovascular age-related macular degeneration previously treated with ranibizumab. 2017, 10 (3):423-426 Int J Ophthalmol
Publisher:
International Journal of Ophthalmology Press
Journal:
International journal of ophthalmology
Issue Date:
Mar-2017
URI:
http://hdl.handle.net/11287/620341
DOI:
10.18240/ijo.2017.03.15
PubMed ID:
28393034
Additional Links:
https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28393034/
Note:
This article is freely available from the PubMed Central. Click on the Additional Link above to access the full-text.
Type:
Journal Article
Language:
en
ISSN:
2222-3959
Appears in Collections:
Ophthalmology (West of England Eye Unit); 2017 RD&E publications

Full metadata record

DC FieldValue Language
dc.contributor.authorLim, Rachel Hui Fenen
dc.contributor.authorGupta, Bhaskaren
dc.contributor.authorSimcock, Peteren
dc.date.accessioned2017-05-26T11:00:44Z-
dc.date.available2017-05-26T11:00:44Z-
dc.date.issued2017-03-
dc.identifier.citationIntravitreal aflibercept in neovascular age-related macular degeneration previously treated with ranibizumab. 2017, 10 (3):423-426 Int J Ophthalmolen
dc.identifier.issn2222-3959-
dc.identifier.pmid28393034-
dc.identifier.doi10.18240/ijo.2017.03.15-
dc.identifier.urihttp://hdl.handle.net/11287/620341-
dc.description.abstractTo report the change in visual acuity and central macular thickness (CMT) following treatment with intravitreal aflibercept injections in patients with neovascular age-related macular degeneration (nAMD) with suboptimum response to ranibizumab.en
dc.language.isoenen
dc.publisherInternational Journal of Ophthalmology Pressen
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28393034/en
dc.rightsArchived with thanks to International journal of ophthalmologyen
dc.subjectWessex Classification Subject Headings::Ophthalmologyen
dc.titleIntravitreal aflibercept in neovascular age-related macular degeneration previously treated with ranibizumab.en
dc.typeJournal Articleen
dc.identifier.journalInternational journal of ophthalmologyen
dc.description.noteThis article is freely available from the PubMed Central. Click on the Additional Link above to access the full-text.en
dc.type.versionPublisheden

Related articles on PubMed

All Items in RD&E Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.